VIP: Handling, Storage, and Reconstitution Guide

This VIP handling and storage guide covers laboratory best practices for working with vasoactive intestinal peptide as a lyophilized research material. It addresses reconstitution for in vitro preparation, cold-chain storage, aliquoting, and documentation, with particular attention to the reduced stability of the reconstituted peptide. Every step below is framed as laboratory procedure, not human-use instruction.

VIP Handling and Storage Fundamentals

VIP ships as a solid, white lyophilized powder in a sealed glass vial. In the lyophilized state it should be stored at or below 25 degrees Celsius, sealed and protected from heat, light, and moisture. For extended storage, keeping the vial lyophilized and refrigerated or frozen supports material integrity over time.

As a 28-residue peptide (molecular formula C147H237N43O43S, molecular weight near 3326.83 g/mol), VIP is handled with standard peptide discipline: limit exposure to ambient humidity, avoid warming the sealed vial repeatedly, and allow a cold vial to equilibrate to room temperature before opening to reduce condensation. These conditions mirror the general practice used across the neuroregulatory peptides, including the approach in the DSIP handling guide.

The 10 mg vial is supplied lyophilized because the dry solid is the most robust form for transit and storage. A larger, highly basic peptide like VIP is particularly worth protecting in its lyophilized state, since keeping the powder sealed and dry preserves the stability advantage the dry form provides. Logging the receiving condition and the assigned storage temperature on arrival gives a clean baseline for any later troubleshooting.

Reconstitution for In Vitro Preparation

For in vitro work, VIP is typically reconstituted with bacteriostatic water added slowly down the vial wall, allowing the powder to dissolve without vigorous agitation. Directing the liquid against the glass rather than onto the powder reduces foaming and localized shear, which matters for a peptide that is already less stable once in solution. Swirling gently rather than shaking, and allowing a few minutes for the material to dissolve fully, helps preserve the peptide. The exact working concentration depends on the assay, and the choice should follow the study design rather than any fixed formula. Researchers planning experiments can revisit the VIP research applications to align concentration with the model.

Reconstitution should be performed under clean conditions using calibrated pipettes and appropriate PPE, in line with institutional SOPs. Confirming the solution is clear and free of visible particulate, and recording solvent, volume, and final concentration, keeps the preparation reproducible. This is standard laboratory reagent preparation, not a route of administration.

Reconstituted Stability and Aliquoting

A key handling note for VIP is that the reconstituted peptide is less stable than the lyophilized form. Preparing solution close to the time of use, and dividing it into single-use aliquots, limits both degradation and repeated freeze-thaw cycles. Maintaining consistent conditions throughout the study period and monitoring storage records is part of quality assurance. Labeling each aliquot supports traceability:

• Compound name and lot number.
• Reconstitution solvent and final concentration.
• Preparation date and assigned storage temperature.
• Storage location for an auditable cold chain.

Documentation and COA Verification

Each VIP batch ships with a third-party-verified certificate of analysis (COA) documenting purity by HPLC or reverse-phase chromatography, mass-spectrometry identity confirmation, and lot number, testing date, and method details. Recording the lot number against experimental results ties data back to a specific batch. Sample COAs can be requested before purchase to confirm testing parameters; material and documentation are available on the VIP product page.

Consistent handling and COA verification are what make the mechanistic readouts described in the VIP mechanism of action reproducible across runs. Teams handling other neuroregulatory peptides can compare notes with the Cerebrolysin handling guide, which follows similar cold-chain principles.

Reading the COA in full is worth the effort. The HPLC or reverse-phase purity value describes how much of the material is the intended peptide, while the mass-spectrometry result confirms identity against the expected mass near 3326.83 g/mol. Taking both together, and recording the lot number against each dataset, lets a laboratory attach a defensible quality claim to a specific batch and trace any result back to the material that produced it.

Cold-Chain and Traceability

Because the reconstituted peptide is less stable than the lyophilized form, cold-chain discipline is central rather than incidental for VIP. Holding the dry vial and any prepared aliquots at their assigned temperatures, minimizing time at ambient conditions during handling, and preparing solution close to the time of use all limit the window in which the less stable dissolved form can degrade. Logging each transfer keeps the material in a known state from receipt through experiment.

Traceability completes the picture. Tying every aliquot to a lot number and a certificate of analysis, and holding that documentation with the raw data, keeps results auditable well after the bench work is done. For a peptide whose solution form is time-sensitive, this record is what allows a laboratory to separate a genuine signal from an artifact of aged material.

Safety and Compliance

Handle VIP as a research chemical: qualified personnel only, engineering controls where required, and disposal in accordance with institutional and applicable regulations. Given the reduced stability of the reconstituted material, maintaining consistent storage conditions and complete records throughout the study period supports both quality assurance and audit readiness.

For research use only. VIP is an investigational research peptide and is not approved for human or veterinary use. All handling guidance refers to laboratory procedure only.